1 Min Read
Aug 23 (Reuters) - Cynata Therapeutics Ltd
* Positive data from cyp mscs in 2nd preclinical asthma study Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.